Marie Louise Holm Milo

Marie Louise Holm Milo is a Clinical Associate Professor at the Department of Oncology, Faculty of Medicine, Aalborg University, Denmark. She also serves as a senior physician (Afdelingslæge) at Aalborg University Hospital, where she integrates clinical practice with academic research in oncology. Her work is closely tied to the Clinical Cancer Research Center (CCRC) and the Clinical Research Unit (CRU), contributing to national and international collaborations in breast cancer research.

Research Interests: Dr. Milo's research centers on clinical and epidemiological investigations in breast cancer, with a focus on the side effects of radiation therapy. This includes both acute and long-term toxicities, particularly cardiotoxicity, radiation-induced lung injury, and impacts on physical and mental well-being. She actively contributes to improving radiotherapy safety and precision through dosimetric audits and advanced treatment planning techniques.

Recent Research Trends: Her recent publications (2023–2025) reflect a strong emphasis on population-based cohort studies, such as the DBCG RT-Nation and DBCG IMN2 projects. These studies explore cardiac radiation doses, internal mammary node irradiation, and the development of national auto-segmentation models to standardize radiotherapy planning. Her work bridges clinical oncology, medical physics, and public health, aiming to enhance treatment quality and patient outcomes.

Collaborations and Affiliations:

• Department of Oncology, Aalborg University Hospital
• Faculty of Medicine, Aalborg University
• Clinical Cancer Research Center (CCRC)
• Clinical Research Unit (CRU)
• Danish Breast Cancer Group (DBCG)
• National and international oncology networks

Scientific Contributions:

• Co-author of 14 research outputs, including high-impact journal articles in Radiotherapy and Oncology and The Lancet Regional Health - Europe
• Active contributor to national consensus guidelines for breast cancer radiotherapy
• Developer of open-source and consensus-based auto-segmentation tools for radiotherapy planning

Advising and Grants: While no formal list of students is provided, her leadership in multi-center studies and research groups suggests active mentorship and supervision of junior researchers and clinicians. She participates in collaborative grant-funded projects through DBCG and institutional research units, focusing on treatment optimization and long-term survivorship.

Laboratories and Research Groups: Dr. Milo is a key member of the research group at the Department of Oncology, Aalborg University Hospital. This group conducts high-quality clinical and translational research in oncology, with strong ties to medical physics and epidemiology. The team works on protocol development, dosimetric validation, and large-scale data analysis to support evidence-based oncology practice.